Sarah Cannon Research Institute

Denver, Colorado 80218

We've found

3 trials

at this facility

Safety, Dose Tolerance, Pharmacokinetics, and Pharmacodynamics Study of CPX-POM in Patients With Advanced Solid Tumors

Status: Enrolling, Phase I
Updated: 12/31/1969

from

Denver, CO

A Study of RGX-104 With or Without Nivolumab in Patients With Advanced Solid Malignancies and Lymphoma

Status: Enrolling, Phase I
Updated: 12/31/1969

from

Denver, CO

A Phase 1 Dose-escalation Study of FF 10832 for the Treatment of Advanced Solid Tumors

Status: Enrolling, Phase I
Updated: 12/31/1969

from

Denver, CO

Use our guide to learn which trials are right for you!